Literature DB >> 17867381

Vitamin D receptor gene (VDR) associations with cancer.

Martha L Slattery1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17867381      PMCID： PMC2409269          DOI： 10.1111/j.1753-4887.2007.tb00332.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN： 0029-6643            Impact factor:   7.110


× No keyword cloud information.
  23 in total

Review 1.  Molecular epidemiology of vitamin D receptor gene variants.

Authors:  J M Zmuda; J A Cauley; R E Ferrell
Journal:  Epidemiol Rev       Date:  2000       Impact factor: 6.222

2.  Association of A vitamin D receptor polymorphism with sporadic breast cancer development.

Authors:  J E Curran; T Vaughan; R A Lea; S R Weinstein; N A Morrison; L R Griffiths
Journal:  Int J Cancer       Date:  1999-12-10       Impact factor: 7.396

3.  Vitamin D receptor genotype and breast cancer in Latinas (United States).

Authors:  S A Ingles; D G Garcia; W Wang; A Nieters; B E Henderson; L N Kolonel; R W Haile; G A Coetzee
Journal:  Cancer Causes Control       Date:  2000-01       Impact factor: 2.506

4.  No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

Authors:  A M Dunning; S McBride; J Gregory; F Durocher; N A Foster; C S Healey; N Smith; P D Pharoah; R N Luben; D F Easton; B A Ponder
Journal:  Carcinogenesis       Date:  1999-11       Impact factor: 4.944

5.  Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.

Authors:  Rama D Mittal; Parmeet K Manchanda; Sanjay Bhat; Hemant K Bid
Journal:  BJU Int       Date:  2007-04       Impact factor: 5.588

6.  Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States).

Authors:  S A Ingles; J Wang; G A Coetzee; E R Lee; H D Frankl; R W Haile
Journal:  Cancer Causes Control       Date:  2001-09       Impact factor: 2.506

7.  Variants of the VDR gene and risk of colon cancer (United States).

Authors:  M L Slatter; K Yakumo; M Hoffman; S Neuhausen
Journal:  Cancer Causes Control       Date:  2001-05       Impact factor: 2.506

8.  Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium.

Authors:  H S Kim; P A Newcomb; C M Ulrich; C L Keener; J Bigler; F M Farin; R M Bostick; J D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-08       Impact factor: 4.254

9.  Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.

Authors:  A P Chokkalingam; K A McGlynn; Y T Gao; M Pollak; J Deng; I A Sesterhenn; F K Mostofi; J F Fraumeni; A W Hsing
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

10.  Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.

Authors:  Yue Xu; Atsuko Shibata; John E McNeal; Thomas A Stamey; David Feldman; Donna M Peehl
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-01       Impact factor: 4.254
View more
  24 in total

1.  Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population.

Authors:  Wani Arjumand; Shiekh Tanveer Ahmad; Amlesh Seth; Ashish Kumar Saini; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-09-20

2.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

3.  A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression.

Authors:  Alanna Roff; Robin Taylor Wilson
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-06       Impact factor: 4.292

4.  Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.

Authors:  Sara Karami; Paul Brennan; Philip S Rosenberg; Marie Navratilova; Dana Mates; David Zaridze; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Vsevolod Matveev; Neonila Szeszenia-Dabrowska; Ivana Holcatova; Meredith Yeager; Stephen Chanock; Idan Menashe; Nathaniel Rothman; Wong-Ho Chow; Paolo Boffetta; Lee E Moore
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

5.  In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells.

Authors:  Mukul K Mittal; Jeremy N Myers; Smita Misra; Charvann K Bailey; Gautam Chaudhuri
Journal:  Biochem Biophys Res Commun       Date:  2008-05-14       Impact factor: 3.575

6.  Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany.

Authors:  Yasemin Tastan; Peter Herbert Kann; Hans-Rudolf Tinneberg; Peyman Hadji; Ulf Müller-Ladner; Uwe Lange
Journal:  Clin Rheumatol       Date:  2016-03-31       Impact factor: 2.980

7.  Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study.

Authors:  Julie Bienertová-Vašků; Klára Drábová; Filip Zlámal; Josef Tomandl; Michal Kýr; Zbyněk Šplíchal; Jaroslav Štěrba
Journal:  Tumour Biol       Date:  2016-01-14

8.  Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Authors:  Katherine D Crew
Journal:  ISRN Oncol       Date:  2013-02-26

9.  The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV.

Authors:  Xing Yao; Huazong Zeng; Guolei Zhang; Weimin Zhou; Qiang Yan; Licheng Dai; Xiang Wang
Journal:  Biomed Res Int       Date:  2013-03-23       Impact factor: 3.411

10.  Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population.

Authors:  Jian Jia; Chong Shen; Lina Mao; Keming Yang; Chen Men; Yiyang Zhan
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-05       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.